Endoscopy and MRI for restaging early rectal cancer after neoadjuvant treatment.

Abstract

AIM

Chemoradiotherapy has great potential to downstage rectal cancer. Response assessment has been investigated in locally advanced rectal cancer, but not in early stage rectal cancer. The aim is to characterize the diagnostic accuracy of endoscopy performed by surgical endoscopists compared to (diffusion-weighted) MRI only and a multimodal approach combining (diffusion-weighted) MRI and endoscopic information both analysed by an abdominal radiologist for response assessment in early rectal cancer after neoadjuvant chemoradiotherapy.

CONCLUSION

Good and complete responders after chemoradiation of early stage rectal cancer can be best assessed using a multimodality approach combining endoscopy and diffusion weighted MRI.

MATERIALS AND METHODS

Patients treated with neoadjuvant chemoradiotherapy for early distal rectal cancer (cT1-3N0) followed by transanal endoscopic microsurgery were included. Three separate re-assessment groups were analysed for response assessment using endoscopic evaluation alone versus (DWI-)MRI alone versus the combination of endoscopy with (DWI-) MRI with focus on sensitivity and specificity and analysis using receiver operating characteristic curves.

RESULTS

Three cohorts (N=36, N=25 and N=25, respectively) were analysed for response assessment. Of the endoscopy cohort, 16 of the 36 patients had a complete response. Areas under the curve were 0.69 (0.66-0.74; pooled sensitivity 55.3%, pooled specificity 80.0%). Agreement for scoring separate endoscopic features was poor to moderate. Of the (DWI-)MRI cohort, 11 of the 25 patients had a complete response. Area under the curve for (DWI-)MRI alone was 0.55 (sensitivity 72.7%, specificity 42.9%).The AUC improved to 0.68 (sensitivity 90.9%, specificity 75.0%) when (DWI)-MRI was combined with endoscopic information with 11 out of 25 patients with a complete response. Most accurate response assessment was made by combining endoscopy and diffusion weighted MRI with a high negative predictive value (90.9%).

More about this publication

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • Publication date 14-09-2022

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.